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1. Introduction
Quality of life (QoL) is a broad multidimensional concept that usually includes subjective
evaluations of both positive and negative aspects of life [1]. What makes it challenging to
measure is that, although the term “quality of life”has meaning for nearly everyone and ev‐
ery academic discipline, individuals and groups can define it differently. Philosophers were
concerned with the nature of human existence and defined the “good life”, ethicists debated
the shift in health-care decision-making for the concept of “sanctity of life” to “QoL” and so‐
cial utility, environmentalists have placed emphasis upon attributes and conditions of the
physical and biological environment, economists were concerned with the allocation of re‐
sources to achieve alternating goals, psychologists considered human needs and their fulfill‐
ment, where as sociologists have advanced a social systems approach in which indicators of
QoL are seen as variables in the total system and its subsystems. Physicians focused on
health- and illness-related variables and nurses, on keeping with the discipline’s holistic ap‐
proach, took the broadest view in defining life quality, yet because of their frequent preoccu‐
pation with the physiological status, they tend to contaminate their operationalization of the
concept with disease-specific items [2,3]. And within these disciplines, scientists have de‐
fined QoL from different perspectives, such considerations as objective indicators, subjective
view, life goals, needs satisfaction, and components of life. WHO defines Quality of Life as
individuals perception of their position in life in the context of the culture and value systems
in which they live and in relation to their goals, expectations, standards and concerns. It is a
broad ranging concept affected in a complex way by the person's physical health, psycho‐
logical state, level of independence, social relationships, personal beliefs and their relation‐
ship to salient features of their environment [4,5].
Although health is one of the important domains of overall quality of life, there are other
domains as well—for instance, jobs, housing, schools, the neighborhood. Aspects of culture,
values, and spirituality are also key aspects of overall quality of life that add to the complex‐
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ity of its measurement [6,7]. Nevertheless, researchers have developed useful techniques
that have helped to conceptualize and measure these multiple domains and how they relate
to each other [8].
Health-related quality of life (HRQoL) was adapted from the more general and wide-rang‐
ing concept ‘quality of life’. The concept of HRQoL and its determinants have evolved since
the 1980s to encompass those aspects of overall quality of life that can be clearly shown to
affect health—either physical or mental [9]. Health-related quality of life is a multi-dimen‐
sional concept that includes domains related to physical, mental, emotional and social func‐
tioning. It goes beyond direct measures of population health, life expectancy and causes of
death, and focuses on the impact health status has on quality of life [10,11].
In the field of medical research, medical sociologist and scientists were concerned with eval‐
uating aspects of life that are affected by disease or treatment for disease, hence, the term
health-related QoL were used and included as a criterion for determining the outcome of ill‐
ness and treatment [12,13].
HRQoL refers to the physical, psychological and social domains of health that are unique to
each individual [3].Each of these domains can be measured by the objective assessments of
functioning or health status and the subjective perceptions of health. Other valued aspects of
life exist that are not generally considered as “health,” including income, freedom, and the
environment. It has been defined as follows: “HRQoL is defined as the value assigned to du‐
ration of life as modified by impairments, functional states, perceptions, and social opportu‐
nities that are influenced by disease, injury, treatment, or policy” [8]. Another definition is
“HRQoL can be defined as the functional effect of an illness and its consequent therapy
upon a patient, as perceived by a patient” [14]. Lehman, Rachuba and Postrado (1995) also
suggested that "HRQoL is the optimum level of mental, physical, role, and social function‐
ing, including relationships, and perceptions of health, fitness, life satisfaction, and well-be‐
ing" [15]. And Bird et al. (2000) defined HRQoL as: "the degree to which valued aspects of a
person’s life have been influenced, positively or negatively by health and/or health-related
interventions such as medical care" [12].
Over the years,  consensus has been established that  HRQoL is  a  multidimensional  con‐
cept. As such, HRQoL is generally divided into 3 domains: physical, social, and psycholog‐
ical (Guyattet al.1993, Testa MA & Simonson DC, 1996). In the physical domain, perception
and observation of normal or disrupted corporal functioning, such as mobility, pain, and
nausea, are evaluated. In the social domain, the performance of societal functions is stud‐
ied; these include activities of daily living and responsibilities in and out of the home, such
as those associated with family, friends, and colleagues. In the psychological domain, men‐
tal and emotional functioning—for example, patients’ concerns, distress, and mood—are ex‐
amined [4,6].
Briefly, HRQoL refers to the subjective perception of the effect of a disease or its treatment
on one’s health and overall QoL. It includes physical, psychological, and social dimensions
of health as assessed by the patient. It is clearly influenced by the individual’s beliefs, life
experiences, personality, and expectations [6]. Emphasizing the inherently subjective nature
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of HRQoL is important. The physical dimensions of health (eg, disabilities, impaired physi‐
cal strength) can be assessed “objectively” through either healthcare personnel or different
instruments. These measurements provide information about the patient’s “health status” or
“functioning.” HRQoL, on the other hand, assesses how the presence of the disease’s physi‐
cal symptoms, such as impairment of physical functioning and reduced stamina, affect one’s
overall well being, life satisfaction, or QoL. This means that two individuals with either sim‐
ilar physical health or equal severity of the disease could have vastly different HRQoL. Evi‐
dence accumulated over the last 10–15 years has clearly demonstrated that HRQoL
measurements correlate with “objective” measures of physical health and predict traditional
“hard outcomes” (ie, hospitalization and mortality) [16]. They also add additional informa‐
tion to the assessment of the overall well being of patients with chronic medical conditions.
Clinicians and public health officials have used HRQoL and well-being to measure the ef‐
fects of chronic illness, treatments, and short- and long-term disabilities. While there are sev‐
eral existing measures of HRQoL and well-being, methodological development in this area
is still ongoing.
Recently there has been growing recognition of health‐related quality of life as an important
indicator of the quality of care for patients with various illnesses. Monitoring patient-report‐
ed outcomes (PROs) including self-reported mental and functional health of individuals
with chronic disease states is important for assuring optimal disease management and pa‐
tient satisfaction. The subjective or self-reported state of well being, as it relates to the health
condition, also known as “health related quality of life”, is a core PRO measure in individu‐
als with End stage renal disease (ESRD). QoL may also serve as a prognostic measure and
predictor for such other outcomes as survival.
In order to understand the relationship among the disease, its treatment, and HRQoL, the
concept of illness intrusiveness must be understood. Illness intrusiveness was introduced to
represent illness-induced disruptions to lifestyles, activities, and interests that compromise
QoL [17]. Conceptualized as a facet of the chronic disease experience common across condi‐
tions, illness intrusiveness is a fundamental determinant of HRQoL. The central hypothesis
is that disease (ie, pain, fatigue, disability) and treatment factors (ie, time required for treat‐
ment, untoward side effects) indirectly influence subjective well being and HRQoL through
their effects on illness intrusiveness. For example, depriving the individual of the gratifying
consequences of psychologically meaningful activities could affect the patient’s HRQoL.
Psychological and social factors act as moderator variables that influence both the magni‐
tude of illness intrusiveness, which is occasioned by disease and treatment factors, and the
degree to which illness intrusiveness compromises QoL [18].
2. Quality of life of hemodialysis patients
Over the past few decades, quality of life research endpoints have emerged as valuable re‐
search tools in assessing the outcome of therapeutic intervention in chronic diseases [19].
End stage renal disease is one such chronic disease causing a high level of disability in dif‐
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ferent domains of the patients' lives, leading to impaired QoL [20,21]. The availability of var‐
ious renal replacement therapies (RRT) has reduced the severity of symptoms and resulted
in longer survival of ESRD patients [22]. Hemodialysis therapy is time-intensive, expensive,
and requires fluid and dietary restrictions. Long-term dialysis therapy itself often results in
a loss of freedom, dependence on caregivers, disruption of marital, family, and social life,
and reduced or loss of financial income [23]. Hemodialysis alters the life style of the patient
and family and interferes with their lives. The major areas of life affected by ESRD and its
treatment includes employment, eating habits, vacation activities, sense of security, self-es‐
teem, social relationships, and the ability to enjoy life [24]. Due to these reasons, the physi‐
cal, psychological, socioeconomic, and environmental aspects of life are negatively affected,
leading to compromised QoL [25].
Survival of ESRD patients has been largely improved nowadays because of medical prog‐
ress, advanced technology, and beter patient care. Accumulated data in the recent decade
show that health-related quality of life markedly influences dialysis outcomes. Attention
thus needs to be focused not only on how long but also on how well ESRD patients live [26].
Compared with the general population, ESRD patients treated with hemodialysis have sig‐
nificantly impaired HRQoL [27].
Evaluation of HRQoL in patients with chronic diseases is becoming very important. HRQoL
assessment helps to plan the individual strategy of treatment, to determine the efficacy of
medical intervention, and to evaluate the quality of medical care. In comparison with
HRQoL of the general population, it provides the opportunity to evaluate the psychological
burden of chronic disease, and the effect of specific treatment [28].Some studies have shown
international differences in HRQoL of ESRD patients treated with hemodialysis [29, 30].
An increasing number of professionals feel that HRQoL assessment is essential to evaluating
quality and effectiveness of ESRD patient care, comparing alternative treatments and RRT
modalities, improving clinical outcomes, facilitating complex rehabilitation of ESRD pa‐
tients, and enhancing patient satisfaction. Several authors have suggested that regular
HRQoL monitoring become part of regular ESRD patient assessment and incorporated into
the continuous quality assurance and quality improvement systems [31,32].
ESRD is a life-threatening disease that leads to numerous and severe symptoms and compli‐
cations. These severe comorbid conditions will have a major impact on the affected patients’
HRQoL. RRTs are able to alleviate, but they are very intrusive and cure neither the disease
nor its symptoms. Patients suffering from ESRD need RRTs to survive, but they also expect
to achieve a certain level of well being. In industrialized countries achieving survival is not
enough for a treatment to be considered “successful” unless it also yields an appreciable
gain in HRQoL [33,34]. Thus, the results of studies suggest that the QoL of hemodialysis pa‐
tients is considerably impaired compared to that of the healthy subjects, especially with re‐
spect to the physical, psychological and social relationship domains [35,36]. In a previous
DOPPS study, lower scores in several measures of HRQoL, particularly PCS, were found to
be strongly associated with higher risk of death in Japan, Europe, and the United States [16].
Other studies have shown that patients on hemodialysis have a poor health-related quality
of life (HRQoL) and present with complications such as depression, malnutrition, and in‐
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flammation. Many of them suffer from impaired cognitive functioning such as memory loss
and abnormally low concentration, as well as other unhealthy physical, mental, and social
aspects of life that can, and do, affect even the simplest activities of daily life [37,38]. On the
other hand, many researchers emphasize that an improvement in HRQoL reduces the com‐
plications associated with this disease, or at least makes them more tolerable [39]. Therefore,
it is useful to determine the level of renal function related to the decreasing point of HRQoL
for the adequate intervention to enhance HRQoL in time. Improving QoL and other PROs in
the dialysis patient population has evolved as a goal for renal replacement therapy.
3. Factors associated with health-related quality of life in patients under
going hemodialysis
End-stage renal disease patients undergoing hemodialysis (HD) has a considerable impact
on the functional status and health-related QoL perceived by the patient as it is accompa‐
nied by symptoms that affect daily life [40].Over the years, several studies have assessed
HRQoL in different ESRD populations. These reports reveal numerous sociodemographic,
clinical, and psychosocial factors that are associated with impaired HRQoL.
Sociodemographic factors: It has been repeatedly demonstrated patients undergoing hemo‐
dialysis that female patients consistently report worse HRQoL than men [40,41]. Women
had lower QoL scores than men, as already reported by the studies [42,43]; this may be ex‐
plained by women's multiple domestic tasks and responsibilities that, unlike men, they can‐
not circumvent [44]. Also, one potential explanation may be the more negative disease
perception and the increased prevalence of depression in women. Moreno et al.,(1996) in
their multicenter cross-sectional study [36], and Sesso et al., (2003) in their prospective co‐
hort study, also found that higher socioeconomic level was significantly related to better
QoL [45]. A lower social status, characterized by lower education, worse financial situation,
or lack of employment, has also been consistently associated with impaired QoL [41,46].
This association is important, as vocational and educational rehabilitation could substantial‐
ly improve HRQoL. The association of age with HRQoL is quite complex and illustrates the
complexity of the QoLconcept.Some studies conducted in different countries also demon‐
strated that age was strongly inversely associated with the physical domain scores [25].As
age increases in the elderly, physical function of the body decreases [46-48]. The subjective
QoL for elderly patients, however, varies depending on their expectations and beliefs. It
could be surprisingly good compared to their younger counterparts [49].
Clinical factors: Several clinical factors are strongly associated with HRQoL in hemodialysis
patients. The underlying kidney disease leading to renal failure, the presence and severity of
diabetes [50,51] and comorbid conditions in general [49,52] and congestive heart failure in
particular predict impaired QoL [53]. Anemia is highly prevalent in patients undergoing HD
and is associated with adverse clinical outcomes and diminished HRQoL [54-59]. The most
prominent symptoms of anemia are fatigue, dyspnea, and diminished sense of well-being.
Less common symptoms include difficulty concentrating, dizziness, sleep disorders, cold in‐
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tolerance, and headaches [60]. Walters et al. (2002) assessed health-related QoL, depressive
symptoms, anemia, and malnutrition at hemodialysis initiation and found that 56% of the
sample group (422) had a hemoglobin levels less than 10g/dl [38]. Chronic inflammation,
presence of malnutrition, and different medications’ side effects have been reported to pre‐
dict worse HRQoL [31]. However, it is important to note that the different comorbidity indi‐
ces are used to measure comorbid burdens, and clinical and sociodemographic factors only
explains a fraction of HRQoL variability.
Duration of dialysis plays an important role affecting QoL in dialysis patients. According to
Vasilieva (2006), in linear regression analysis, duration of dialysis was a significant inde‐
pendent predictors of the low physical component score (PCS) in hemodialysis patients [61].
A similar observation was made by Anees et al. (2011); duration of dialysis had a reverse
correlation with QoL. As duration of dialysis increases, QoL of dialysis patients deteriorates
[62]. In another study, QoL was better in hemodialysis patients with a duration less than 8
months than patients with a dialysis duration more than 8 months [63].
Psychological/psychosocial factors: Several psychosocial factors have also been shown to
strongly predict HRQoL scores. The expanding awareness about objective parameters and
their impact on HRQoL is complemented by few studies on subjective symptoms and their
influence on HRQoL in CKD [64-66]. The symptom burden that these patients struggle with
include, fatigue [59,64,65], cognitive difficulties [59,64], sleep disturbances [34,59,64,67], sex‐
ual dysfunction [59,64], pain and depression [59,64,65], most of which are interlinked [65,67.
While larger studies on pre-dialysis ESRD patients are lacking, existing ones confirm the
negative impact of these symptoms on HRQoL [34,59,66].
In relation to psychological status, the a study by Mollaoglu (2004) indicated that two third
of ESRD patients in Turkey had depression and found an association between depressed
mood and health-related QoL [63]. The higher depression scores the lower health-related
QoL scores. She explained that as a direct influence of chronic renal insufficiency on health-
related QoL. Another study indicated that the mental health was significantly higher for pa‐
tients treated in the United States than in Europe [68]. In another study by Jofre, Lopez-
Gomez &Valderrabano (2000) who reviewed the factors affecting the QoL of renal failure
patients, they found that the prevalence of depression is within 70% in the dialysis popula‐
tion using Beck Depression Inventory (BDI), they also indicated that depression has a signif‐
icant impact on the perception of QoL [40]. Anxiety is another psychological response to
hemodialysis patients and is related to the awareness of one's illness and the sense of de‐
pendency on the machine. Patients are concerned about the unpredictability of the illness
and the disruption of their lives, they are chronically ill and fear dying [24].
Body image is also affected by dialysis treatment, making patients feel different, unattrac‐
tive, and ill at ease within their own bodies. Access surgery often results in multiple scar‐
ring, involving the arms and chest. A fistula which is regarded as "very good" by dialysis
staff can be seen as a horrible disfigurement by the patient, who may try to conceal it from
friends and the curious stares of strangers. Many feel embarrassed in front of their partners
and feel that nobody could find them attractive anymore [63,64].
Hemodialysis828
Anxiety, loss of control, body image and sexual problems, social support, and unemploy‐
ment are all factors that strongly influence QoL in hemodialysis patients. The utmost signifi‐
cance of these factors is further underlined by the fact that many of them are modifiable.
Unfortunately, little attention is given to assess the potentially modifiable psychosocial
stressors in hemodialysis patients.
Sleep disorders are highly prevalent in patients with renal impairment. The most frequent
sleep disorders, such as restless legs syndrome, periodic leg movements in sleep, insomnia,
and obstructive sleep apnea, are associated with significantly impaired HRQoL in patients
with moderate renal failure not yet requiring RRTs as well as in patients on hemodialysis
[17,32]
4. Assessment of health-related quality of life in patientsundergoing
hemodialysis
Health-related QoL assessment, as a supplement to more objective clinical indicators, is be‐
coming more topical in view of the increasing questioning of the effectiveness and appropri‐
ateness of many existing medical treatments and methods of organizing health services
[2,4]. The US Centers for Disease Control and Prevention CDC (1993) suggested that: meas‐
uring health-related QoL can help determine the burden of preventable diseases, injuries,
and disabilities, and it can provide valuable new insights into the relationships between
health-related QoL and risk factors. Measuring health-related QoL will help monitor prog‐
ress in achieving the notions' health objectives. Analysis of health-related QoL surveillance
data can identify subgroups with relatively poor perceived health and help to guide inter‐
ventions to improve their situations and avert more serious consequences [69].
In the field of nephrology, the evaluation of health-related QoL involves determining the ef‐
ficiency and effectiveness of the different forms of renal replacement therapy (e.g. HD and
peritoneal dialysis), evaluating the efficiency and effectiveness of the different types of other
treatments applied to patients with ESRD (e.g., recombinant human erythropoietin therapy)
and follow-up of the evolution of individual renal patients [43].
Different generic disease-specific instruments and domain-specific instruments have been
used for assessing the QoL in patients undergoing hemodialysis (Germin-Petrovic et al.
2011).
4.1. Generic instruments
Measures which implicitly or explicitly aim to tap health-related QoL. They encompass the
dimensions of physical, mental and social health [69]. These instruments are intended for
general use, irrespective for the illness or condition of the patient. These generic question‐
naires may often be applicable to healthy people, too [13]. The Sickness Impact Profile, the
Medical Outcome Study 36-Item Short Form, and the Nottingham Health Profile are exam‐
ples of the generic instruments.
Quality of Life in Patients Undergoing Hemodialysis
http://dx.doi.org/10.5772/45929
829
4.1.2. Medical outcome study 36-item short Form (SF-36)
The SF-36 developed by Ware et al. in 1993 evaluates general health status, it is designed to
provide assessments involving generic health concepts that are not specific to any age, dis‐
ease or treatment groups. Emphasis is placed upon physical, social, and emotional function‐
ing. It can be either self-assessed or administered by a trained interviewer. As the name
implies, there are 36 questions addressing physical health and mental health [13].
4.1.3. The Nottingham Health Profile (NHP)
The Nottingham Health Profile (NHP) was developed to be used in epidemiological studies
of health and disease [70]. It consists of two parts. Part I contains 38 yes/no items in 6 dimen‐
sions: pain, physical mobility, emotional reactions, energy, social isolation and sleep. Part II
contains 7 general yes/no questions concerning daily living problems. The two parts may be
used independently. Part I is scored using weighted values which give a range of possible
scores from zero (no problems at all) to 100 (presence of all problems within a dimension).
4.1.4. Sickness impact profile
A 136-item self- or interviewer-administered, behaviorally-based, health status question‐
naire. Everyday activities in 12 categories (sleep and rest, emotional behavior, body care and
movement, home management, mobility, social interaction, ambulation, alertness behavior,
communication, work, recreation and pastimes, and eating) are measured. Respondents en‐
dorse items that describe themselves and are related to their health. The SIP is scored ac‐
cording to the number and type of items endorsed. Scoring can be done at the level of
categories and dimensions as well as at the total SIP level. It may be either interviewer- or
self-administered [13].
4.1.5. Disease-specific instruments
4.1.5.1. Quality of life index-D (QLI-D)
The Quality of Life Index (QLI) was developed in the USA during the 1980s as a measure
of morbidity for application in both normal and unwell populations [71]. The original in‐
strument, with the addition of six dialysis-specific items, was developed and tested in pa‐
tients receiving haemodialysis [71]; factor analysis confirmed instrument construction. The
instrument  comprises  two sections assessing respondent  satisfaction and relative impor‐
tance of  each domain,  respectively.  Each section has 32 items,  with eight  items per  do‐
main. Six-point ordinal response scales range from ‘very dissatisfied’ or ‘very unimportant’
(1), to ‘very satisfied’ or ‘very important’ (6). Scoring is complicated and the developers rec‐
ommend a computer programme. In summary, importance scores are used to weight satis‐
faction scores;  index or domain scores range from 0 to 30,  where higher scores indicate
better quality of life.
Regarding evidence in relation to kidney disease, reliability was supported for the QLI in a
one month time interval for dialysis patients. High internal consistency was also reported
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in  a  small  study by [71]and reproduced in a  further  study with a  larger  sample of  pa‐
tients [71]. Additional items for haemodialysis patients relating to treatment were added to
each section (Satisfaction with various domains and Importance of the domain to the indi‐
vidual) in Ferrans and Powers 1985). Items were endorsed by patients receiving haemodial‐
ysis. A transplant version is also available which included two items relating to the potential
for a successful transplant. This is for patients receiving haemodialysis and on the trans‐
plant list.
A four factor structure was supported in Ferrans and Powers (1985) of Health and function‐
ing, socioeconomic, psychological/spiritual and family. A high order factor was revealed
representing Quality of Life. Moderate correlation of QLI-D scores with a life satisfaction
questionnaire has been reported [71]. Further convergent validity is supported for each do‐
main and life satisfaction, with higher correlations for the Psychological/spiritual domain.
Moderate correlation was reported between scores from the QLI-D and other patient-report‐
ed measures of symptoms and psychological adjustment to disease. Moderate correlation of
scores has been reported between QLI-D and symptoms.
A larger population was recruited in another study by the developers [13]. This included
349 patients from a haemodialysis unit and questionnaires mailed to patients. 20% of pa‐
tients had missing values greater than 15% and overall computable responses were available
from 46% of participants invited. A 46% response rate was obtained to postal administration
of the questionnaire [13].
4.1.5.2. Kidney Disease Quality of Life Short Form (KDQOL-SF)
The KDQOL-SF includes both general measures and measures specific to patients with kid‐
ney disease. The general measures were based on questions from the 36-item Short-Form
Health Survey (SF-36), developed by Ware and Sherbourne [73]. Previous data support the
use of the SF-36 and the KDQOL-SF as research instruments to HRQoL [74]. The internal
consistency and reliability are similar among translations of the SF-36 and the KDQOL-SF
[9,68]. Patient responses to the SF-36 questions were used to determine scores for the mental
component summary (MCS) and the physical component summary (PCS). The scales for
MCS and PCS are derived from eight different subscales: physical functioning role (physical,
bodily pain, general health, and vitality) and social functioning role (emotional, and mental
health).
The KDQOL-SF includes questions that supplement the SF-36. These additional questions
were designed to assess the particular health-related concerns of individuals with kidney
diseases and ESRD patients treated by dialysis [74]. The kidney disease component summa‐
ry (KDCS) score, which corresponds to the MCS and PCS of the SF-36, is derived from 11
subscales: symptoms/problems, effects of kidney disease on daily life, burden of kidney dis‐
ease, work status, cognitive function, quality of social interaction, sexual function, sleep, so‐
cial support, dialysis staff encouragement, and patient satisfaction.
The SF-36 and kidney disease–targeted portions of the questionnaire were scored according
to the manual by Ware et al (1993) and the KDQOL scoring manual (Hays et al.1994) [74].
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On all scales, the possible scores range from 0 to 100; higher scores indicate more or better
functioning, or better quality of life. The summary scales have the same interpretation, but
do not span the entire 0 to 100 range.
4.1.5.3. Kidney Disease Questionnaire (KDQ)
This 26 itemed questionnaire was developed in Canada with the involvement of patients re‐
ceiving haemodialysis and empirically by factor analysis. Five domains included are: Physi‐
cal symptoms (6 individualised symptoms identified by the patient); Fatigue: 6); Depression
(5); Relationships (6); Frustration (3). Responses are scored in a 7 point Likert scale during
the last 2 weeks. It is reported to take 10 to 15 minutes to complete.
Reproducibility is supported with ICCs above 0.80 for all domains. Construct validity is re‐
ported with moderate correlations with analogous domains using the SIP. Trial data [76],
provide support for responsiveness with significant improvement in scores for patients re‐
ceiving treatment for anaemia which was consistent with score changes on the SIP.
4.1.6. Renal Quality of Life Profile (RQLP)
The Renal Quality of Life profile (RQLP) is a 43 itemed questionnaire with a 5 point Likert
scale for responses. Five dimensions include: Eating and drinking, Physical activities, Lei‐
sure time, Psychosocial activities and Impact of treatment. It was developed adopting a
comprehensive methodology involving patients and clinicians in the UK [77].
Principal component factor analysis supported the five dimensions. A high response rate is
reported in Barton et al., [78].The RQLP scores were responsive to change in a trial of phar‐
macy care compared to standard care for patients receiving HD. Effect sizes were moderate
[78]. Moderate correlation is reported between the RQLP and SF-36 dimensions which were
similar in construct.
4.1.7. CHOICE Health Experience Questionnaire (CHEQ)
The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study was designed to
evaluate the effectiveness of alternative dialysis prescription. As part of the CHOICE study,
the CHEQ as patient-reported HRQoL instrument was developed to specifically comple‐
ment the SF-36; be sensitive to dialysis treatment modalities and regimes; and be useful for
longitudinal evaluation. A comprehensive, patientcentred approach was used during devel‐
opment. Items were derived from interviews with patients; literature; and clinicians’ exper‐
tise [79]. The questionnaire has 83 items addressing 21 domains: the 8 domains of the SF-36,
8 additional generic domains (cognitive functioning, sexual functioning, sleep, work, recrea‐
tion, travel, finances, and general quality of life); and 5 ESRD-specific domains (diet, free‐
dom, body image, dialysis access. The original study byWu and colleagues (2001) provided
some evidence for the reliability and validity of the scales. Adequate internal consistency is
reported for most domains in Wu et al. (2001) [79].
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4.1.8. Renal dependantindividualised quality of life questionnaire
This instrument was developed out of an instrument used in relation to diabetes, the Audit
of Diabetes Dependent Quality of Life (ADDQoL) diabetes-specific individualized quality of
life questionnaire. From a small study with patients in eight U.K. renal clinics each of the 13
ADDQoL items were found relevant and important for renal patients. Additional items
were also identified by patients including physical appearance, dependency, freedom, re‐
strictions of fluid intake, and societal prejudice [80]. No psychometric data for the new in‐
strument were reported. No further studies using the instrument were identified.
4.2. Domain-specific instruments
4.2.1. Barthel Index of disability (BI)
The BI was developed in 1965 (Barthel, 1965)and later modified by Granger and coworkers
(1979) as a scoring technique that measures the patient’s performance in 10 activities of daily
life [81,82]. The BI is considered a reliable disability scale for stroke patients. The items can
be divided into a group that is related to self-care (feeding, grooming, bathing, dressing,
bowel and bladder care, and toilet use) and a group related to mobility (ambulation, trans‐
fers, and stair climbing). The maximal score is 100 if 5-point increments are used, indicating
that the patient is fully independent in physical functioning. The lowest score is 0, represent‐
ing a totally dependent bedridden state. The MRS measures independence rather than per‐
formance of specific tasks The BI examines the ability to perform normal or expected
activities [13]. In this way, mental as well as physical adaptations to the neurological deficits
are incorporated. The scale consists of 6 grades, from 0 to 5, with 0 corresponding to no
symptoms and 5 corresponding to severe disability.
4.2.2. McGill Pain Questionnaire (MPQ)
The McGill Pain Questionnaire, also known as McGill pain index, is a scale of rating pain
developed at McGill University by Melzack and Torgerson [83].
To use the questionnaire, circle the words that describe your pain but do not circle more
than one word in a group. Then when you have that done, go back and circle the three
words in groups 1-10 that most convey your pain response. Pick the two words in groups
11-15 that do the same thing. Then pick one word in group 16. Finally, pick 1 word in
groups 17-20. At the end you should have seven words that you can take to your doctor that
will help describe both the quality of your pain and the intensity of it [13].
5. Improving health-related quality of life in patientsundergoing
hemodialysis
There is growing recognition of health-related QoL issues in ESRD patients undergoing he‐
modialysis. Considerable progress has been made in the treatment and health intervention
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of chronic kidney disease, however, health-related QoL continues to be a significant prob‐
lem for patients receiving hemodialysis [31,39]. Hemodialysis patients are subjected to mul‐
tiple physiological and psychological stressors and may be threatened with many potential
losses and life style changes as they experience problems with disease-specific symptoms.
The combination of a decrease in energy, the unavoidable emergence of socioeconomic
problems, and emotional reactions compounds the stress facing the patient [38, 45]. The ini‐
tiation of long-term dialysis treatment increases survival, but health-related QoL remains
impaired. Therefore, researchers and clinicians generally agree that health-related QoL, its
determinants and treatment options that may preserve subjective well-being merit contin‐
ued investigation [62,63].
Health care workers should understand the health-related QoL of patients undergoing he‐
modialysis. The rich information collected can help health professionals to determine which
patients may be at risk for diminished health-related QoL. It has direct consequences for
clinical decision-making, rehabilitation and management of individual patients [65,72].
Draper (1992) stated that health professionals, in their decisions and actions, can influence
their patient's QoL [84]. Additionally, they will be interested in promoting these conditions,
which enhance life’s quality, and eliminating those that impair it. Health professionals
working in hemodialysis units can direct resources to areas where improvement may be re‐
quired. Patients can then have a greater chance of leading a fulfilling life. All these factors
can positively influence the health-related QoL of patients, and directly benefit the family as
well [62,63, 65]. This could be accomplished through health education and promotion of
awareness about the disease, treatment options, complications and self-care activities. Coun‐
seling, on the other hand, is an important intervention that health professionals - with ap‐
propriate training - can provide. Referral of patients to the appropriate person according to
their needs could be provided by an ordinary health professional who cares for the patient.
Finally, health professionals can develop and implement rehabilitation programs for ESRD
patients undergoing hemodialysis to assist them lead a productive life.
ESRD has a profound effect on HRQoL with the most prominent areas of difficulty being the
physical domains. Hemodynamic instability is a major problem observed in hemodialysis
patients and thus managed carefully. Anemia management in ESRD patients is a challenge
for the health care team. The use of erythropoietin-stimulating agents (ESAs) has become a
routine practice in hemodialysis patients in an effort to correct anemiaand improve HRQoL.
Nonetheless, two simultaneously published trials [85,86] raised concerns regarding the opti‐
mal hemoglobin target levels. Druekeet al. (2006), the CREATE investigators, reported sig‐
nificant increment in HRQoL with higher hemoglobin levels whereas Singh et al. (2006), the
CHOIR investigators, reported no difference in the HRQoL between the low and high hemo‐
globin arms after EPO therapy [86]. Additionally, normalization of hematocrit was shown to
be associated with adverse cardiovascular outcomes in the CHOIR trial (2006). In considera‐
tion of the conflicting results of these publications, the National Kidney Foundation Kidney
Disease Outcomes Quality Initiative (NKF KDOQI) published revised guidelines for the
management of anemia in CKD patients [87], which were further reviewed at the Kidney
Disease: Improving Global Outcomes (KDIGO) international conference. Members voiced a
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general consensus on maintaining target hemoglobin levels in the range of 11.0 to 12.0 g/dL
(KDOQI 2007) and acknowledged the potential for harm associated with levels higher than
13.0 g/dL [87].
Considering the dramatically increasing prevalence of ESRD, the risk of progression of
ESRD with hypertension and the significant impact of the disease on HRQoL, improving
HRQoL is emerging as one of the therapeutic goals in hypertensive individuals. High blood
pressure is managed by an appropriate choice of antihypertensive medications to have a tar‐
get blood pressure of 125/75 mmHg. Cardiovascular risk factors are minimized as ESRD pa‐
tients are at increased risk for coronary heart disease over the standard risk factors,
prevention includes frequent monitoring of plasma lipid levels, diet control, and pharmaco‐
logic treatment of specific hyperlipidemias [87].
The increasing prevalence of ESRD in the older population and the poor prognosis and im‐
paired HRQoL associated with frailty warrant early identification of high-risk patients. Sug‐
gested management strategies to prevent further deterioration include exercise training and
correction of malnutrition, anemia, depression and hormonal imbalances. Growth hormone
supplementation in elderly dialysis patients has been shown to improve muscle perform‐
ance and HRQoL [88], but whether this approach would be helpful in patients with non-di‐
alysis dependent CKD remains to be established.
Among the psychological stressors of ESRD patients undergoing HD, depression and anxi‐
ety are the most common problems encountered. The onset of ESRD and HD impacts signif‐
icantly one's functional state and health-related QoL, it causes major alterations in the
lifestyle of most patients, who may encounter frustration in all areas of life, this frustration
causes depression which is known to be strongly associated to decreased health-related
QoL. This is illustrated in Walters et al. (2002) study that assessed health-related QoL, de‐
pressive symptoms, anemia and malnutrition at HD initiation and found that HD patients
who screened positive for depression (45% of the sample) scored lower on health-related
QoL scale [38]. Anxiety, on the other hand, is detected in HD patients, and is caused by un‐
stable health status leading to fears from worsening health condition, disturbed social rela‐
tions, unemployment and consequent economic alterations, and even death. A study by
White and Grenyer (1999) that aimed at investigating the impact of dialysis on both the pa‐
tient and their partner found that dialysis patients had anxiety as they expressed uncertainty
related to health instability within a progressively debilitating disease state and frequent in‐
terruptions of acute illness episodes [89].
Socioeconomic status is also altered in ESRD patients undergoing HD as chronic dialysis im‐
poses a considerable burden on patients and families [17,38],the relationships of the patients
with family members is altered as there is role reversal, with the assumption of added re‐
sponsibilities by the spouse, resulting in a loss of authority for the patients [63]. Social isola‐
tion and decreased social interactions is observed in HD patients and this is caused by their
health status and the treatment schedules. Another alteration of lifestyle includes the proba‐
ble loss of financial security resulting from lower productivity and income, and possible un‐
employment. All the above factors are strongly related to health-related QoL of HD patients.
Parkerson and Gutman, (2000) assessed health-related QoL of 103 ESRD patients on HD,
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and found that patients living with family reported more social support and better health-
related QoL, general health, emotional well-being, social health and quality of social interac‐
tions than other patients [89].
The development and evaluation of effective interventions to reduce psychological distress,
improve QoL and enhance social intimacy are of clinical and scientific importance to HD pa‐
tients, their family members and healthcare providers. Tsayand Lee, (2005) randomized pa‐
tients with end-stage renal disease to a cognitive–behavioural coping skills and stress
management training programme or standard care (primarily education) [91]. Cognitive–be‐
havioural treatment reduced symptoms of stress and depression, and improved QoL, com‐
pared with a standard care condition. Chang et al. (2004) combined education, vocational
rehabilitation and social support enhancement, and found significant QoL improvements in
ESRD patients [92]. Gross et al. (2004) used a mindfulness-based stress reduction pro‐
gramme in ESRD patients to reduce depression and anxiety, although no QoL improve‐
ments were found. Quality of life therapy (QoLT) is the only cognitive–behavioural
treatment that targets happiness and life satisfaction in multiple life domains (e.g. relation‐
ships, enjoyable activities, self-esteem, etc.) with a specific goal of improving overall QoL
[93]. This is important because the World Health Organization has emphasized the impor‐
tance of a patient’s subjective perception of life in the context of his or her value systems,
goals, expectations and standards.
6. Conclusion
Although advances in dialysis treatment have contributed to improved survival of patients
with end-stage renal disease,such individuals particularly those treated by hemodialysis,
health-related quality of life is much lower for those patients than for the general popula‐
tion. Impaired health-related QoL, dependence on others, and poor rehabilitation all con‐
tribute to physical and emotional disabilities that may persist even in well-dialyzed ESRD
patients. Chronic HD patients are subjected to multiple physiological and psychological
stressors and may be threatened by many potential losses and lifestyle changes. Analysis of
health-related QoL surveillance data can identify subgroups with relatively poor perceived
health and help to guide interventions to improve their situations and avert more serious
consequences. Developments of HD technology, treatment of comorbidities, continuous pa‐
tients' education, social and psychological support may improve the HRQoL in these pa‐
tients.
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